The kind of potency they have depends on the type of their "parent" stem cell and also on their niche.
Current research on progenitor cells focuses on two different applications: regenerative medicine and cancer biology.
[10] Endothelial progenitor cells (EPCs) are one of the main focuses of this field.
[11] This field of regenerative medicine and aging research is still currently evolving.
Recent studies have shown that haematopoietic progenitor cells contribute to immune responses in the body.
Inflammatory cytokines and other factors released during infections will activate haematopoietic progenitor cells to differentiate to replenish the lost resources.